Certara Introduces Hasharc
Certara has announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT). Hasharc has been built on Certara’s OpenPharma technology platform.
The need for increased traceability and security in the life science industry is rapidly increasing, as evidenced by regulations including FDA’s Drug Supply Chain Security Act and the EU’s General Data Protection Regulation (GDPR), along with several clinical trials transparency regulations. Certara’s OpenPharma is being leveraged to address these challenges, especially as they impact patient safety and privacy protections.
The release of Hasharc coincided with Hedera’s own milestone of Open Access for the mainnet network and the introduction of the mirrornet. Hasharc leverages both the mainnet and the mirrornet and builds on other key technological advances of the Hedera platform as well.
Certara has been a Hedera user and partner since its infancy. “We are proud of our association and collaboration with Hedera,” said Jim Nasr, VP of Technology and Innovation, and Head of Certara’s OpenPharma innovation unit.
"We're excited to see Certara be one of the very first implementations of a Hedera mirror node, to provide reporting and analytics for transactions on the Hedera network, particularly for healthcare and supply chain use cases," said Mance Harmon, Co-founder and CEO of Hedera. "We are committed to working alongside Certara on the pioneering work they're doing around OpenPharma and realizing the potential of distributed technology for the healthcare industry to deliver improved outcomes and lower cost for patients."
Last year, Certara leveraged Hedera DLT to develop the OpenPharma proof of concept for tracking the generic drug supply chain in the US. Since then, Certara has continued to evolve its OpenPharma platform to support additional blockchain-based use cases, including: Blockchain-on-FHIR (accessing patient data through HL7 FHIR APIs in real time), real-time data anonymization and lay summary secure collaborations.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
